Let's Talk
Back to Insights

Bill Baruch’s Final Trade: Tempus AI

Bill Baruch went with Tempus AI as his final trade. He described it as a small healthcare technology company with a great management team working to cure cancer, and he added it to portfolios as a starter position last week. Watch the full discussion here.

Share

Latest Insights

Our team at Blue Line Capital, led by founder Bill Baruch, shares their expertise and unique market perspective.
  • 1 min read

Bill Baruch Says the Odds of a Hike Next Week Are Too High

  • 1 min read

Bill Baruch Steps Aside on Amer Sports and Buys Walmart

  • 1 min read

Bill Baruch Sees Significant Value in the Miners and a Complement to Bonds

  • 1 min read

Bill Baruch on What He’s Watching in Nvidia’s Print

Bill Baruch has outlined his checklist prior to Nvidia's report, focusing on initial Rubin deliveries, Blackwell efficiencies, margins, and memory costs. He is particularly interested in management's comments on the financing deal and anticipates potential positive surprises from the non-GPU business, AI models, and CPU products.
View All Insights